SEARCH
Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
NDTV Profit
2022-02-26
Views
4
Description
Share / Embed
Download This Video
Report
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="<? echo $domain; ?>/embed/x88agzz" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
30:49
Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
21:37
Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
26:27
Laurus Labs In Focus | Ask Profit | NDTV Profit
03:23
Ideas for Profit | Laurus Labs - a diversified portfolio of APIs and formulations.
00:00
Laurus Labs In Focus | Ask Profit | NDTV Profit
23:30
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
23:30
Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
12:41
Laurus Labs Forays Into Biotech Segment Via Acquisition
27:08
Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
12:40
Stocks In Focus: ITI, Laurus Labs, L&T, JSW Steel & More | BQ Prime
03:18
Margins Lower On R&D Spends: Laurus Labs
23:36
Laurus Labs' Management Shares Outlook For Q4 & Beyond
